Evidence map›Paper›PMID 26228765›Full record

ArticleJournal of the American Medical Informatics Association : JAMIA2016

An in silico method to identify computer-based protocols worthy of clinical study: An insulin infusion protocol use case.

Anthony F Wong, Ulrike Pielmeier, Peter J Haug, Steen Andreassen, Alan H Morris

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Medical Informatics Association : JAMIA, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Anthony F WongDepartment of Biomedical Informatics, Intermountain Medical Center and University of Utah School of Medicine, Salt Lake City, Utah, USA.
Ulrike PielmeierDepartment of Health Science and Technology, Aalborg University, Aalborg, Denmark.
Peter J HaugDepartment of Biomedical Informatics, Intermountain Medical Center and University of Utah School of Medicine, Salt Lake City, Utah, USA.
Steen AndreassenDepartment of Health Science and Technology, Aalborg University, Aalborg, Denmark.
Alan H MorrisDepartment of Biomedical Informatics, Intermountain Medical Center and University of Utah School of Medicine, Salt Lake City, Utah, USA Pulmonary and Critical Care Divisions, Departments of Medicine, Intermountain Medical Center and University of Utah School of Medicine, Salt Lake City, Utah, USA alan.morris@imail.org.
Aalborg University · DKUniversity of Utah · USIntermountain Medical Center · US

Funding

CLINICAL CENTERS--A NETWORK FOR THE TREAMENT OF ARDN01HR046062 · HR · LDS HOSPITAL · PI MORRIS, ALAN H · 1994 to 2000
$645k
EXPRACORPOREAL CO2 REMOVAL FOR ARDSR01HL036787 · NHLBI · LDS HOSPITAL · PI MORRIS, ALAN H · 1987 to 1989
–
RANDOMIZED TRIAL OF COMPUTERIZED ICU PROTOCOLSR01HS006594 · AHRQ · LDS HOSPITAL · PI EAST, THOMAS D. · 1992 to 1996
–
AHRQ HHS HS 06594NHLBI NIH HHS N01-HR-46062NHLBI NIH HHS R01-HL-36787
6 · The paper itself

Abstract

objectiveDevelop an efficient non-clinical method for identifying promising computer-based protocols for clinical study. An in silico comparison can provide information that informs the decision to proceed to a clinical trial. The authors compared two existing computer-based insulin infusion protocols: eProtocol-insulin from Utah, USA, and Glucosafe from Denmark. MATERIALS AND

methodsThe authors used eProtocol-insulin to manage intensive care unit (ICU) hyperglycemia with intravenous (IV) insulin from 2004 to 2010. Recommendations accepted by the bedside clinicians directly link the subsequent blood glucose values to eProtocol-insulin recommendations and provide a unique clinical database. The authors retrospectively compared in silico 18,984 eProtocol-insulin continuous IV insulin infusion rate recommendations from 408 ICU patients with those of Glucosafe, the candidate computer-based protocol. The subsequent blood glucose measurement value (low, on target, high) was used to identify if the insulin recommendation was too high, on target, or too low.

resultsGlucosafe consistently provided more favorable continuous IV insulin infusion rate recommendations than eProtocol-insulin for on target (64% of comparisons), low (80% of comparisons), or high (70% of comparisons) blood glucose. Aggregated eProtocol-insulin and Glucosafe continuous IV insulin infusion rates were clinically similar though statistically significantly different (Wilcoxon signed rank test P = .01). In contrast, when stratified by low, on target, or high subsequent blood glucose measurement, insulin infusion rates from eProtocol-insulin and Glucosafe were statistically significantly different (Wilcoxon signed rank test, P < .001), and clinically different. DISCUSSION: This in silico comparison appears to be an efficient nonclinical method for identifying promising computer-based protocols.

conclusionPreclinical in silico comparison analytical framework allows rapid and inexpensive identification of computer-based protocol care strategies that justify expensive and burdensome clinical trials.

Indexed as

Computer SimulationDrug Therapy, Computer-AssistedAdolescentAdultAgedAged, 80 and overClinical ProtocolsHumansHyperglycemiaInsulinIntensive Care UnitsMiddle AgedYoung AdultInsulincomparison algorithmscomputer/healthcomputer/informaticspreclinical investigationspreclinical/technical

Identifiers

PMID26228765
PMCPMC5009926
OpenAlexW2112440227

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.